Literature DB >> 30554356

Italian recommendations for diagnosis and management of congenital myasthenic syndromes.

Lorenzo Maggi1, Pia Bernasconi2, Adele D'Amico3, Raffaella Brugnoni2, Chiara Fiorillo4, Matteo Garibaldi5, Guja Astrea6, Claudio Bruno7, Filippo Maria Santorelli6, Rocco Liguori8,9, Giovanni Antonini5, Amelia Evoli10, Enrico Bertini3, Carmelo Rodolico11, Renato Mantegazza2.   

Abstract

Congenital myasthenic syndromes (CMS) are genetic disorders due to mutations in genes encoding proteins involved in the neuromuscular junction structure and function. CMS usually present in young children, but perinatal and adult onset has been reported. Clinical presentation is highly heterogeneous, ranging from mild symptoms to severe manifestations, sometimes with life-threatening respiratory episodes, especially in the first decade of life. Although considered rare, CMS are probably underestimated due to diagnostic difficulties. Because of the several therapeutic opportunities, CMS should be always considered in the differential diagnosis of neuromuscular disorders. The Italian Network on CMS proposes here recommendations for proper CMS diagnosis and management, aiming to guide clinicians in their practical approach to CMS patients.

Entities:  

Keywords:  Congenital myasthenic syndromes; Myasthenia gravis; Myopathy; Neuromuscular junction; Recommendations

Mesh:

Year:  2018        PMID: 30554356     DOI: 10.1007/s10072-018-3682-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  5 in total

1.  Rare Neurologic Diseases and Neurological Sciences: a report for the celebration of the 2020 Rare Diseases Day.

Authors:  Antonio Federico
Journal:  Neurol Sci       Date:  2020-03       Impact factor: 3.307

2.  Favorable outcome of COVID-19 infection in a patient with congenital myasthenic syndrome.

Authors:  Silvia Bonanno; Lorenzo Maggi
Journal:  Neurol Sci       Date:  2021-01-22       Impact factor: 3.307

3.  The First Case of Congenital Myasthenic Syndrome Caused by a Large Homozygous Deletion in the C-Terminal Region of COLQ (Collagen Like Tail Subunit of Asymmetric Acetylcholinesterase) Protein.

Authors:  Nicola Laforgia; Lucrezia De Cosmo; Orazio Palumbo; Carlotta Ranieri; Michela Sesta; Donatella Capodiferro; Antonino Pantaleo; Pierluigi Iapicca; Patrizia Lastella; Manuela Capozza; Federico Schettini; Nenad Bukvic; Rosanna Bagnulo; Nicoletta Resta
Journal:  Genes (Basel)       Date:  2020-12-18       Impact factor: 4.096

Review 4.  Practical approach to respiratory emergencies in neurological diseases.

Authors:  Fabrizio Racca; Andrea Vianello; Tiziana Mongini; Paolo Ruggeri; Antonio Versaci; Gian Luca Vita; Giuseppe Vita
Journal:  Neurol Sci       Date:  2019-12-02       Impact factor: 3.307

5.  The Platform Vector Gene Therapies Project: Increasing the Efficiency of Adeno-Associated Virus Gene Therapy Clinical Trial Startup.

Authors:  Philip J Brooks; Elizabeth A Ottinger; Deanna Portero; Richa Madan Lomash; Asaf Alimardanov; Pramod Terse; Xin Xu; Randy J Chandler; Janelle Geist Hauserman; Eric Esposito; Carsten G Bönnemann; Charles P Venditti; Christopher P Austin; Anne Pariser; Donald C Lo
Journal:  Hum Gene Ther       Date:  2020-10       Impact factor: 5.695

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.